Pharma news
Americas
The Patent Trial and Appeal Board has rejected three inter partes reviews filed by Kyle Bass’s organisation the Coalition for Affordable Drugs. 11 March 2016
Americas
The US Food and Drug Administration has appointed Stephen Ostroff to deputy commissioner for food and veterinary medicine. 10 March 2016
Pharma
Pharmaceutical company AstraZeneca agreed a deal with ProStrakan Group centring on the rights to the Moventig (naloxegol) drug in Europe. 9 March 2016
Africa
The UK Intellectual Property Office has issued a favourable decision on an SPC for an “innovative” combination product. David Carling and Michael Pears of Potter Clarkson explain the reasoning and examine its implications. 9 March 2016
Pharma
In February the English High Court ruled that Actavis had not indirectly infringed a patent owned by Eli Lilly directed to cancer drug Alimta. David Read of Bartle Read reports. 8 March 2016
Americas
Pharmaceutical company Teva has bought Mexico-based Representaciones e Investigaciones Médicas, in a deal totalling $2.3 billion. 8 March 2016
Americas
A US court has brought to a close a patent lawsuit that cancer care company Helsinn Healthcare filed against Teva after determining that Helsinn did not trigger the on-sale bar provision when marketing its anti-cancer drug Aloxi (palonosetron). 4 March 2016
Africa
Despite several UK court decisions centring on second medical use patents, there are no foolproof ways for generic manufacturers to avoid infringement, as Deborah Hart of Kilburn & Strode explains. 3 March 2016
Americas
Amgen and Sandoz are set to go head to head in another patent case, this time centring on Amgen’s arthritis treatment drug Enbrel. 3 March 2016
Asia
Médecins Sans Frontières has urged the Indian Patent Office to reject a Gilead Sciences patent application covering Sovaldi. 2 March 2016